glp-1 garments The rise of GLP–1 drugs, such as Ozempic and Wegovy, is forcing fashion and beauty companies to rethink everything from sizing and fit to product development. With one in eight Americans having GLP-1 Users: Trends on Long-Term

Attorney Nicholas Vocino of Montlick Injury Attorneys is ready to get you the settlement you deserve

GLP-1 is a hormone your body makes

Weight loss is known to trigger compensatory biology: Increased appetite signaling Reduced resting energy expenditure Heightened food reward sensitivity Stopping GLP-1 therapy at peak dose, without tapering and without reinforcing lifestyle strategies at the exact moment hunger returns, does not allow lifestyle behaviors to take over. Emerging real-world data and obesity physiology suggest a different, more clinically relevant path: Gradual dose reduction rather than abrupt cessation Continued, structured dietary and exercise support Active monitoring during the high-risk post-cessation period We still need randomized trials designed specifically to test tapering and lifestyle-anchored maintenance strategies

Only one in five patients on blockbuster weight loss drugs keep the pounds off after stopping the medication, and almost 20 percent regained the weight, a study from Epic Research found.

Vaxess Technologies rebrands as Terrestrial Bio, raises $50M to pivot from vaccines to GLP-1 patches for semaglutide delivery, after AstraZeneca partnership ends.